CryoPort (CryoPort) ROCE % : -26.74% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is CryoPort ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CryoPort's annualized ROCE % for the quarter that ended in Dec. 2023 was -26.74%.

CryoPort ROCE % Historical Data

The historical data trend for CryoPort's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort ROCE % Chart

CryoPort Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-18.38

-9.32

-33.90

-2.80

-9.83

CryoPort Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-2.61	-1.43	-6.57	-4.70	-26.74

CryoPort ROCE % Calculation

CryoPort's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-93.845	/	( ( (1038.746 - 40.851)	+	(957.744 - 45.61) )	/ 2 )
	=	-93.845	/	( (997.895	+	912.134)	/ 2 )
	=	-93.845	/	955.0145
	=	-9.83 %

CryoPort's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-249.768	/	( ( (1000.656 - 44.905)	+	(957.744 - 45.61) )	/ 2 )
	=	-249.768	/	( ( 955.751	+	912.134 )	/ 2 )
	=	-249.768	/	933.9425
	=	-26.74 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

CryoPort (NAS:CYRX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CryoPort ROCE % Related Terms

Thank you for viewing the detailed overview of CryoPort's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CryoPort (CryoPort) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CKX:Germany

Address

112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027

Website

https://www.cryoport.com

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Executives

Robert J Hariri	director	341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton	director, officer: President, CEO	C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman	director	305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich	officer: Chief Financial Officer
Mark W Sawicki	officer: Chief Scientific Officer	3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock	director	7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini	director	20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour	director	PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam	director	4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath	director	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154